about
The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromesLow-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.Suspects in the tale of lupus-associated thrombocytopenia.Downregulation of T-bet/GATA-3 ratio induced by IL-11 treatment is responsible for Th1/Th2 balance restoration in human immune thrombocytopenic purpura (ITP).
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A pilot study of rhuIL-11 treatment of refractory ITP.
@ast
A pilot study of rhuIL-11 treatment of refractory ITP.
@en
A pilot study of rhuIL-11 treatment of refractory ITP.
@nl
type
label
A pilot study of rhuIL-11 treatment of refractory ITP.
@ast
A pilot study of rhuIL-11 treatment of refractory ITP.
@en
A pilot study of rhuIL-11 treatment of refractory ITP.
@nl
prefLabel
A pilot study of rhuIL-11 treatment of refractory ITP.
@ast
A pilot study of rhuIL-11 treatment of refractory ITP.
@en
A pilot study of rhuIL-11 treatment of refractory ITP.
@nl
P1476
A pilot study of rhuIL-11 treatment of refractory ITP.
@en
P2093
P304
P356
10.1002/1096-8652(200103)66:3<172::AID-AJH1041>3.0.CO;2-Q
P577
2001-03-01T00:00:00Z